-
The drug, ATryn has already been approved in Europe. Up until now the drug has been created from blood from human donors. The drug is used to prevent blood clots and would be used during surgery given via an IV, and would not replace normal prescribed blood thinners taken as a normal treatment...
-
Can’t get your LDL down, even with statins, one more drug to the rescue if needed, and can be taken with or without statin use and it should also raise the HDL, but there’s nothing related to prevent heart disease. BD The FDA approved the new drug application of a new formulation of fenofibric...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-06-2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, FDA, Statins, Lipids, HDL, LDL, fenofibric acid
-
You wonder when all of this might end. In China they are recycling Melamine into bricks , just gives you an idea of how solid and durable the product is and the fact that it is not something we want in our bodies. Watch out for teddy bears bearing melamine tainted chocolate. The link...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-07-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, FDA, Business Intelligence, Food, contamination, Melamine, Rost, Congressional Algorithms, Jets, Walgreens
-
In a time whereby we are looking at cures for cancer and other related drugs, items such as this I guess still need consideration too for the safe use of a drug for those long lustrous eye lashes. I guess the old standby product called “mascara” that does the same thing with applying to one’s eyelashes...
-
This is the second approval this week for a generic version of Wellbutrin, earlier this week Watson Pharmaceuticals announced it’s new version. BD The Food and Drug Administration approved a generic copy of an antidepressant made by Impax Laboratories Inc. Regulators gave the drug — a copy of GlaxoSmithKline...
-
Teva Pharma has a generic version, but earlier this year there were some consumer complaints, now the FDA has cleared another manufacturer to produce a generic version, Watson Pharmaceuticals. This is for the 150 mg dose. No word yet as to the availability from the article. ...
-
I will once more mention a potential change of paradigms here with educating the public. Each patient who took the drug is unique. Do we have any information on other drugs they were taking at the same time? Groups will continue to advise against the use until the full facts are known...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, healthcare, Pharma, PHR, FDA, Marketing, paradigms, personal heatlh records
-
Reports of four experimental drugs held up at the FDA emerged in the first two days of this week. “ There’s almost certainly a bit of coincidence at work here, but it also seems to be one more sign of the tough safety climate at the agency these days .” Below are the 4 drugs. No doubt the...
-
Some of the duties will be outsourced, but under the control of a local office, and portions of this provision will need an act of Congress, so I might guess now’s the time, or after the election maybe to tackle this issue. I would also like to see labels on every product stating the city, origin...
-
Whistle blowers today seem to be playing a role in the move towards transparency in more ways than one, not to mention the bounty that could be there if a case goes to court and wrongdoing is found to be the case. BD A New Jersey arbitrator ruled that a former Amgen sales rep can proceed with a...
-
This article states part of the reporting system will include information on the willingness of a doctor to use genetic testing, well first of all we need to help the doctors to bring this full circle with the integration into the clinical side of this, as I have spoken to many MDs and they are aware...
-
We still need more labeling and the ability for consumers to identify products when recalls are sent out. Look a the Heparin recall that failed, and that was a drug. In a recent post I had some suggestions that can be read here, including disallowing “blind” shipments so it’s not a rat race t find...
-
More can be read here as well. The issue goes back to a raid in 2006 of a US warehouse in New Jersey. If the pills were a problem, why were they allowed to continue to ship with allegations that factory test records were falsified. Well I guess this now gives us the answer while the...
-
It seems not a week goes by without a warning being issued from the FDA, so this looks to be a sign of the times, not to put anyone out of business, but to create an awareness. This is transparency folks and the warnings will keep on coming, so get used to it. Who knows, perhaps the competition...
-
The drug evaluation department has the largest increase, and oncologists were difficult to find as most make more money on the outside. I wonder if they can find enough for the drug side of the business, as it is changing every day with new applications and with more information to review, it's...